Metastatic or Locally Advanced Unresectable Solid Tumors Clinical Trial
First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of M1069 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors
The main purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and early signs of efficacy of M1069 in participants with advanced solid malignancies.
|Status||Active, not recruiting|
|Start date||March 2, 2022|
|Completion date||December 14, 2023|